Atomwise, OncoStatyx launch JV to target triple-negative breast cancer; Cancer biotech woos former Spark COO John Furey
→ Celyad is teaming up with Be The Match BioTherapies, a cell and gene therapy solutions provider, on a clinical trial of its non-gene edited allogeneic CAR-T therapies. Be The Match BioTherapies will provide the biotech with over 20 million volunteer donors from their registry of potential blood stem cell donors, the source of starting material for hematopoietic stem cell transplant and cellular therapy.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.